Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colorectal Cancer, Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT01792934
What this trial is testing

Chemotherapy and Maximal Tumor Debulking of Multi-organ Colorectal Cancer Metastases

Who this might be right for
Multi-organ Metastatic Colorectal Cancer
Radboud University Medical Center 478
Testing effectiveness (Phase 2)Ended earlyNCT00493857
What this trial is testing

Study of Nimotuzumab and Irinotecan in Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
YM BioSciences 100
Early research (Phase 1)Ended earlyNCT01134601
What this trial is testing

A Phase I Study of AZD6244 in Combination With Capecitabine and Radiotherapy in Locally Advanced Adenocarcinoma of the Rectum

Who this might be right for
Non-Metastatic Adenocarcinoma of the Rectum
National Cancer Institute (NCI) 1
Early research (Phase 1)Study completedNCT01270698
What this trial is testing

Study of IMMU-130 in Patients With Relapsed/Refractory Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Gilead Sciences 26
Early research (Phase 1)Ended earlyNCT04044430
What this trial is testing

Encorafenib, Binimetinib, and Nivolumab in Treating Microsatellite Stable BRAF V600E Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colon AdenocarcinomaMetastatic Colorectal AdenocarcinomaMetastatic Microsatellite Stable Colorectal Carcinoma+25 more
University of California, San Francisco 2
Early research (Phase 1)Study completedNCT00026364
What this trial is testing

ZD 1839 Plus Combination Chemotherapy in Treating Patients With Locally Advanced, Locally Recurrent, or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
National Cancer Institute (NCI) 22
Not applicableEnded earlyNCT02614157
What this trial is testing

Lateral Lymph Node Dissection After Neoadjuvant Chemo-radiation in Advanced Low Rectal Cancer

Who this might be right for
Rectal Cancer
West China Hospital 51
Testing effectiveness (Phase 2)Study completedNCT01348412
What this trial is testing

Hepatic Arterial Chemotherapy With Raltitrexed and Oxaliplatin Versus Standard Chemotherapy in Unresectable Liver Metastases From Colorectal Cancer After Conventional Chemotherapy Failure

Who this might be right for
Colorectal CancerLiver Metastases
Centre Georges Francois Leclerc 31
Early research (Phase 1)Study completedNCT01460134
What this trial is testing

CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

Who this might be right for
CD27 Expressing B-cell Malignancies for Example Hodgkin's LymphomaChronic Lymphocytic LeukemiaMantle Cell Lymphoma+7 more
Celldex Therapeutics 90
Testing effectiveness (Phase 2)UnknownNCT01249521
What this trial is testing

Dual Targeting of Vascular Endothelial Growth Factor-A Together With Angiopoietins in Chemotherapy-naïve Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Austin Health 40
Not applicableActive Not RecruitingNCT07385521
What this trial is testing

The Use of Artificial Intelligence for the Prediction of Recurrence After Resection of Colorectal Liver Metastases

Who this might be right for
Colorectal Liver Metastasis (CRLM)Liver ResectionHepatectomy+1 more
Francesco De Cobelli 1,000
Testing effectiveness (Phase 2)Ended earlyNCT02654639
What this trial is testing

Ph 2 Study of TAS-102 / Bevacizumab Maintenance Therapy Post Induction Chemotherapy in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Georgetown University 4
Testing effectiveness (Phase 2)UnknownNCT02068131
What this trial is testing

Recombinant Anti-tumor and Anti-virus Protein for Injection Plus Xeloda in Treatment of Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 30
Testing effectiveness (Phase 2)Study completedNCT03101475
What this trial is testing

Synergism of Immunomodulation and Tumor Ablation

Who this might be right for
Colorectal CancerLiver Metastases
European Organisation for Research and Treatment of Cancer - EORTC 22
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07807800
What this trial is testing

DES-1357 in People With Deficient Mismatch Repair (dMMR)/Microsatellite Instability-High (MSI-H) Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Metastatic Colorectal Cancer (CRC)
D. E. Shaw Research, LLC 88
Not applicableStudy completedNCT03717519
What this trial is testing

Elevated Platelet Count as Prognostic Factor in Colorectal Cancer With Synchronous Liver Metastases

Who this might be right for
Colorectal CancerColorectal CarcinomaStage IV Colon Cancer
Azienda Ospedaliera Universitaria Integrata Verona 196
Not applicableStudy completedNCT05396807
What this trial is testing

REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients

Who this might be right for
Metastatic Colon Cancer
University of Rome Tor Vergata 106
Not applicableLooking for participantsNCT05501353
What this trial is testing

Explore Biomarkers Associated With Prognosis of Recurrent and Metastatic CRC After Surgery by Multi-omics Methods

Who this might be right for
Colorectal Cancer Metastatic
Second Affiliated Hospital, Zhejiang University, School of Medicine 125
Not applicableUnknownNCT05714475
What this trial is testing

Pancreas Resection for Colorectal Metastasis: Retrospective Study

Who this might be right for
Pancreas MetastasesColorectal Cancer
Ospedale Generale Di Zona Moriggia-Pelascini 15
Testing effectiveness (Phase 2)Looking for participantsNCT06149481
What this trial is testing

Phase I/II Study of the Combination Immunotherapy Regimen: SX-682, TriAdeno Vaccine, Retifanlimab and IL-15 Agonist N-803 (STAR15) for Metastatic Colorectal Cancer (mCRC)

Who this might be right for
Metastatic Colorectal Cancer
National Cancer Institute (NCI) 60
Next Page